LB-100

Unknown Manufacturer

LB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).

Generate AI report

Overview

LB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).

Technical identifiers

Chemical Formula: C₁₃H₂₀N₂O₄
CAS Number: 1632032-53-1
UNII ID: 0C1JUU9S0L

Drugs